Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Other financing activities: 2018-2021

Historic Other financing activities for Avidity Biosciences (RNA) over the last 4 years, with Dec 2021 value amounting to $17.1 million.

  • Avidity Biosciences' Other financing activities fell 88.30% to $1.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $9.8 million, marking a year-over-year decrease of 71.37%. This contributed to the annual value of $17.1 million for FY2021, which is 29.01% down from last year.
  • Avidity Biosciences' Other financing activities amounted to $17.1 million in FY2021, which was down 29.01% from $24.0 million recorded in FY2020.
  • In the past 5 years, Avidity Biosciences' Other financing activities registered a high of $24.0 million during FY2020, and its lowest value of $17,000 during FY2019.
  • In the last 3 years, Avidity Biosciences' Other financing activities had a median value of $17.1 million in 2021 and averaged $13.7 million.
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 71.67% in 2019, then soared by 141,229.41% in 2020.
  • Yearly analysis of 4 years shows Avidity Biosciences' Other financing activities stood at $60,000 in 2018, then crashed by 71.67% to $17,000 in 2019, then soared by 141,229.41% to $24.0 million in 2020, then declined by 29.01% to $17.1 million in 2021.